Registro:

Referencias:

• Brekken, R.A., Sage, E.H., SPARC, a matricellular protein: At the crossroads of cell-matrix communication (2000) Matrix Biol, 19, pp. 569-580
• Bradshaw, A.D., Sage, E.H., SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury (2001) J. Clin. Invest, 107, pp. 1049-1054
• Funk, S.E., Sage, E.H., The Ca 2+ -binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells (1991) Proc. Natl. Acad. Sci USA, 88, pp. 2648-2652
• Funk, S.E., Sage, E.H., Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts (1993) J. Cell Physiol, 154, pp. 53-63
• Kupprion, C., Motamed, K., Sage, E.H., SPARC (BM-40, Osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells (1998) J. Biol. Chem, 273, pp. 29635-29640
• Sage, E.H., Vernon, R., Funk, S., Everitt, E., Angello, J., SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca 2+ -dependent binding to the extracellular matrix (1989) J. Cell. Biol, 109, pp. 341-356
• Barker, T.H., Baneyx, G., Cardo-Vila, M., Workman, G.A., SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity (2005) J. Biol. Chem, 280, pp. 36483-36493
• Yan, Q., Sage, E.H., SPARC, a matricellular glycoprotein with important biological functions (1999) J. Histochem. Cytochem, 47, pp. 1495-1506
• Ledda, M.F., Bravo, A.I., Adris, S., Bover, L., The expression on the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma (1997) J. Invest. Dermatol, 108, pp. 210-214
• Rempel, S.A., Ge, S., Gutiérrez, J.A., SPARC: A potential diagnostic marker of invasive meningiomas (1999) Clin. Cancer Res, 5, pp. 237-241
• Bos, T.J., Cohn, S.L., Kleinman, H.K., Murphy-Ulrich, J.E., International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions (2004) Matrix Biol, 23, pp. 63-69
• Sato, N., Fukushima, N., Maehara, N., Matsubayashi, H., SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions (2003) Oncogene, 22, pp. 5021-5030
• Ledda, M.F., Adris, S., Bravo, A.I., Kairiyama, C., Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells (1997) Nat. Med, 3, pp. 171-175
• Woelfle, U., Cloos, J., Sauter, G., Riethdorf, L., Molecular signature associated with bone marrow micrometastasis in human breast cancer (2003) Cancer Res, 63, pp. 5679-5684
• Campo McKnight, D.A., Sosnoski, D.M., Koblinski, J.E., Gay, C.V., Roles of osteonectin in the migration of breast cancer cells into bone (2005) J. Cell Biochem, 97, pp. 288-302
• Mok, S.C., Chan, W.Y., Wong, K.K., Muto, M.G., Berkowitz, R.S., SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells (1996) Oncogene, 12, pp. 1895-1901
• Yiu, G.K., Chan, W.Y., Ng, S.W., Chan, P.S., SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells (2001) Am. J. Pathol, 159, pp. 609-622
• Chlenski, A., Liu, S., Crawford, S.E., Volpert, O.V., SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis (2002) Cancer Res, 62, pp. 7357-7363
• Alvarez, M.J., Prada, F., Salvatierra, E., Bravo, A.I., Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity (2005) Cancer Res, 65, pp. 5123-5132
• Kairiyama, C., Slavutsky, I., Larripa, I., Morvillo, V., Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN (1995) Pigment Cell Res, 8, pp. 121-131
• Gorg, A., Obermaier, C., Boguth, G., Harder, A., The current state of two-dimensional electrophoresis with immobilized pH gradients (2000) Electrophoresis, 21, pp. 1037-1053
• Heukeshoven, J., Dernick, R., Improved silver staining procedure for fast staining in phastSystem development unit. I. staining of sodium dodecyl sulfate gels (1988) Electrophoresis, 9, pp. 28-32
• Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels (1996) Anal. Chem, 68, pp. 850-858
• Reed, L.J., Muench, H., A simple method of estimating fifty per cent endpoints (1938) Am. J. Hyg, 27, pp. 493-497
• Chomczynski, P., Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction (1987) Anal. Biochem, 162, pp. 156-159
• Bradshaw, A.D., Reed, M.J., Sage, E.H., SPARC-null mice exhibit accelerated cutaneous wound closure (2002) J. Histochem. Cytochem, 50, pp. 1-10
• Bradshaw, A.D., Puolakkainen, P., Dasgupta, J., Davidson, J.M., SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength (2003) J. Invest Dermatol, 120, pp. 949-955
• Reiss, K., Maretzky, T., Ludwig, A., Tousseyn, T., ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling (2005) EMBO J, 24, pp. 742-752
• Utton, M.A., Eickholt, B., Howell, F.V., Wallis, J., Doherty, P., Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells (2001) J. Neurochem, 76, pp. 1421-1430
• Paradies, N.E., Grunwald, G.B., Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function (1993) J. Neurosci. Res, 36, pp. 33-45
• Prada, F., Benedetti, L.G., Bravo, A.I., Alvarez, M.J., SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth (2007) J. Invest. Dermatol, , in press, DOI:10.1038/sj.jid.5700962
• Haass, N.K., Smalley, K.S., Li, L., Herlyn, M., Adhesion, migration and communication in melanocytes and melanoma (2005) Pigment Cell Res, 18, pp. 150-159
• Kuphal, S., Bosserhoff, A.K., Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma (2006) Oncogene, 25, pp. 248-259
• Silye, R., Karayiannakis, A.J., Syrigos, K.N., Poole, S., E-cadherin/catenin complex in benign and malignant melanocyte lesions (1998) J. Pathol, 186, pp. 350-355
• Li, G., Satyamoorthy, K., Herlyn, M., Dynamics of cell interactions and communications during melanoma development (2002) Crit. Rev. Oral Biol. Med, 13, pp. 62-70
• Robert, G., Gaggioli, C., Bailet, O., Chavey, C., SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development (2006) Cancer Res, 66, pp. 7516-7523
• Alonso, S.R., Tracey, L., Ortiz, P., Perez-Gomez, B., A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis (2007) Cancer Res, 67, pp. 3450-3460
• O'Sullivan, J., Whyte, L., Drake, J., Tenniswood, M., Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis (2003) Cell Death Differ, 10, pp. 914-927
• Leskov, K.S., Klokov, D.Y., Li, J., Kinsella, T.J., Boothman, D.A., Synthesis and functional analyses of nuclear clusterin, a cell death protein (2003) J. Biol. Chem, 278, pp. 11590-11600
• Pucci, S., Bonanno, E., Pichiorri, F., Angeloni, C., Spagnoli, L.G., Modulation of different clusterin isoforms in human colon tumorigenesis (2004) Oncogene, 23, pp. 2298-2304
• Miyake, H., Hara, I., Kamidono, S., Gleave, M.E., Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model (2001) Clin. Cancer Res, 7, pp. 4245-4252
• Hoeller, C., Pratscher, B., Thallinger, C., Winter, D., Clusterin regulates drug-resistance in melanoma cells (2005) J. Invest Dermatol, 124, pp. 1300-1307
• Tai, I.T., Dai, M., Owen, D.A., Chen, L.B., Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy (2005) J. Clin. Invest, 115, pp. 1492-1502
• Shi, Q., Bao, S., Maxwell, J.A., Reese, E.D., Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation (2004) J. Biol. Chem, 279, pp. 52200-52209
• Volmer, M.W., Radacz, Y., Hahn, S.A., Klein-Scory, S., Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis (2004) Proteomics, 4, pp. 1324-1334
• Volmer, M.W., Stuhler, K., Zapatka, M., Schoneck, A., Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer (2005) Proteomics, 5, pp. 2587-2601
• Wegrowski, Y., Perreau, C., Martiny, L., Haye, B., Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells (1999) Exp. Cell Res, 247, pp. 475-483
• Jin, G., Howe, P.H., Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos (1999) Eur. J. Biochem, 263, pp. 534-542
• Reed, M.J., Vernon, R.B., Abrass, I.B., Sage, E.H., TGF-b 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors (1994) J. Cell Physiol, 158, pp. 169-179
• Ford, R., Wang, G., Jannati, P., Adler, D., Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: Regulation via a TGF-beta-dependent pathway (1993) Exp. Cell Res, 206, pp. 261-275
• Bassuk, J.A., Pichler, R., Rothmier, J.D., Pippen, J., Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis (2000) Kidney Int, 57, pp. 117-128
• Eustace, B.K., Sakurai, T., Stewart, J.K., Yimlamai, D., Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness (2004) Nat. Cell Biol, 6, pp. 507-514
• Celis, J.E., Gromov, P., Cabezon, T., Moreira, J.M., Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: A novel resource for biomarker and therapeutic target discovery (2004) Mol. Cell. Proteomics, 3, pp. 327-344
• Garrido, C., Schmitt, E., Cande, C., Vahsen, N., HSP27 and HSP70: Potentially oncogenic apoptosis inhibitors (2003) Cell Cycle, 2, pp. 579-584
• Garrido, C., Fromentin, A., Bonnotte, B., Favre, N., Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones (1998) Cancer Res, 58, pp. 5495-5499
• Lemieux, P., Oesterreich, S., Lawrence, J.A., Steeg, P.S., The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells (1997) Invasion Metastasis, 17, pp. 113-123
• Aldrian, S., Trautinger, F., Frohlich, I., Berger, W., Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro (2002) Cell Stress Chaperones, 7, pp. 177-185
• Aldrian, S., Kindas-Mugge, I., Trautinger, F., Frohlich, I., Overexpression of Hsp27 in a human melanoma cell line: Regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system (2003) Cell Stress Chaperones, 8, pp. 249-257
• Gronborg, M., Kristiansen, T.Z., Iwahori, A., Chang, R., Biomarker discovery from pancreatic cancer secretome using a differential proteomics approach (2006) Mol. Cell. Proteomics, 5, pp. 157-171
• Lafon-Cazal, M., Adjali, O., Galeotti, N., Poncet, J., Proteomic analysis of astrocytic secretion in the mouse: Comparison with the cerebrospinal fluid proteome (2003) J. Biol. Chem, 278, pp. 24438-24448
• Fevrier, B., Raposo, G., Exosomes: Endosomal-derived vesicles shipping extracellular messages (2004) Curr. Opin. Cell. Biol, 16, pp. 415-421
• Clayton, A., Turkes, A., Navabi, H., Mason, M.D., Tabi, Z., Induction of heat shock proteins in B-cell exosomes (2005) J. Cell Sci, 118, pp. 3631-3638
• Thery, C., Zitvogel, L., Amigorena, S., Exosomes: Composition, biogenesis and function (2002) Nat. Rev. Immunol, 2, pp. 569-579

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------